PTGS2 and benign prostatic hyperplasia: The present study employed CXB prophylactically to guarantee pre-inhibition of COX-2, which specifically impacts the relationship between COX-2 and the EGFR–ERK1/2 pathway in both the initiation and progression of testosterone-induced BPH in rats.